EBAG_FLAST
ID EBAG_FLAST Reviewed; 314 AA.
AC P80036; Q9F1K1;
DT 01-NOV-1991, integrated into UniProtKB/Swiss-Prot.
DT 15-JAN-2008, sequence version 2.
DT 03-AUG-2022, entry version 80.
DE RecName: Full=Endo-beta-N-acetylglucosaminidase;
DE EC=3.2.1.96;
DE AltName: Full=DI-N-acetylchitobiosyl beta-N-acetylglucosaminidase;
DE AltName: Full=Endo-Fsp;
DE AltName: Full=Mannosyl-glycoprotein endo-beta-N-acetyl-glucosaminidase;
DE Flags: Precursor;
OS Flavobacterium sp. (strain SK1022).
OC Bacteria; Bacteroidetes; Flavobacteriia; Flavobacteriales;
OC Flavobacteriaceae; Flavobacterium; unclassified Flavobacterium.
OX NCBI_TaxID=148444;
RN [1]
RP NUCLEOTIDE SEQUENCE [GENOMIC DNA], FUNCTION, SUBCELLULAR LOCATION,
RP BIOPHYSICOCHEMICAL PROPERTIES, SUBSTRATE SPECIFICITY, AND MUTAGENESIS OF
RP TYR-60; ASP-168; GLY-169; ASP-173; ASP-174; GLU-175 AND TYR-238.
RX PubMed=11515537; DOI=10.1271/bbb.65.1542;
RA Fujita K., Nakatake R., Yamabe K., Watanabe A., Asada Y., Takegawa K.;
RT "Identification of amino acid residues essential for the substrate
RT specificity of Flavobacterium sp. endo-beta-N-acetylglucosaminidase.";
RL Biosci. Biotechnol. Biochem. 65:1542-1548(2001).
RN [2]
RP PROTEIN SEQUENCE OF 48-314.
RX PubMed=1935974; DOI=10.1111/j.1432-1033.1991.tb16359.x;
RA Takegawa K., Mikami B., Iwahara S., Morita Y., Yamamoto K., Tochikura T.;
RT "Complete amino acid sequence of endo-beta-N-acetylglucosaminidase from
RT Flavobacterium sp.";
RL Eur. J. Biochem. 202:175-180(1991).
CC -!- FUNCTION: Cleaves asparagine-linked oligomannose and hybrid, but not
CC complex, oligosaccharides from glycoproteins.
CC {ECO:0000269|PubMed:11515537}.
CC -!- CATALYTIC ACTIVITY:
CC Reaction=Endohydrolysis of the N,N'-diacetylchitobiosyl unit in high-
CC mannose glycopeptides and glycoproteins containing the
CC -[Man(GlcNAc)2]Asn- structure. One N-acetyl-D-glucosamine residue
CC remains attached to the protein, the rest of the oligosaccharide is
CC released intact.; EC=3.2.1.96;
CC -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC pH dependence:
CC Optimum pH is 5.0-9.0. {ECO:0000269|PubMed:11515537};
CC -!- SUBUNIT: Monomer.
CC -!- SUBCELLULAR LOCATION: Secreted {ECO:0000269|PubMed:11515537}.
CC -!- SIMILARITY: Belongs to the glycosyl hydrolase 18 family. {ECO:0000305}.
CC ---------------------------------------------------------------------------
CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC ---------------------------------------------------------------------------
DR EMBL; AB053207; BAB20938.1; -; Genomic_DNA.
DR PIR; S19538; S19538.
DR AlphaFoldDB; P80036; -.
DR SMR; P80036; -.
DR CAZy; GH18; Glycoside Hydrolase Family 18.
DR GO; GO:0005576; C:extracellular region; IEA:UniProtKB-SubCell.
DR GO; GO:0033925; F:mannosyl-glycoprotein endo-beta-N-acetylglucosaminidase activity; IEA:UniProtKB-EC.
DR GO; GO:0005975; P:carbohydrate metabolic process; IEA:InterPro.
DR InterPro; IPR016289; Endo-Fsp.
DR InterPro; IPR001223; Glyco_hydro18_cat.
DR InterPro; IPR001579; Glyco_hydro_18_chit_AS.
DR InterPro; IPR017853; Glycoside_hydrolase_SF.
DR Pfam; PF00704; Glyco_hydro_18; 1.
DR PIRSF; PIRSF001103; Endo-b-N-acetylglucosaminidase; 1.
DR SUPFAM; SSF51445; SSF51445; 1.
DR PROSITE; PS01095; GH18_1; 1.
DR PROSITE; PS51910; GH18_2; 1.
PE 1: Evidence at protein level;
KW Direct protein sequencing; Glycosidase; Hydrolase; Secreted; Signal.
FT SIGNAL 1..47
FT /evidence="ECO:0000269|PubMed:1935974"
FT CHAIN 48..314
FT /note="Endo-beta-N-acetylglucosaminidase"
FT /id="PRO_0000077053"
FT DOMAIN 55..309
FT /note="GH18"
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU01258"
FT REGION 14..54
FT /note="Disordered"
FT /evidence="ECO:0000256|SAM:MobiDB-lite"
FT ACT_SITE 175
FT /note="Proton donor"
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU01258"
FT SITE 174
FT /note="Important for substrate specificity"
FT MUTAGEN 60
FT /note="Y->A: Reduced catalytic activity."
FT /evidence="ECO:0000269|PubMed:11515537"
FT MUTAGEN 168
FT /note="D->N: Loss of catalytic activity."
FT /evidence="ECO:0000269|PubMed:11515537"
FT MUTAGEN 169
FT /note="G->L: Reduced catalytic activity."
FT /evidence="ECO:0000269|PubMed:11515537"
FT MUTAGEN 173
FT /note="D->E,N: Reduced catalytic activity."
FT /evidence="ECO:0000269|PubMed:11515537"
FT MUTAGEN 174
FT /note="D->E,N: Reduced catalytic activity toward hybrid
FT type oligosaccharides."
FT /evidence="ECO:0000269|PubMed:11515537"
FT MUTAGEN 175
FT /note="E->A: Loss of catalytic activity."
FT /evidence="ECO:0000269|PubMed:11515537"
FT MUTAGEN 238
FT /note="Y->A: Reduced catalytic activity."
FT /evidence="ECO:0000269|PubMed:11515537"
FT CONFLICT 194
FT /note="W -> G (in Ref. 2; AA sequence)"
FT /evidence="ECO:0000305"
SQ SEQUENCE 314 AA; 32936 MW; 0227CD75BE4DC5BF CRC64;
MQFGIVAAIA DGGRTARAGG SVRPPRRPPA SHTAWGLPRG RPTGQPHATP TKSGPTSIAY
VEVNNDQLAN VGRYQLANGA NAFDVAIIFA ANINWNGSKA VLYNNENVQA TLDDAATQIR
PLQAKGIKVS LSILGNHQGA GIANFPTQAA AEDFAAQVSA TVSKYGLDGV DLDDEYSDYG
TNGTPQPNQQ SIGWLISALR ADVPGKLISF YDIGPASSAL SSSSSTIGSK LDYAWNPYYG
TYSAPSIPGL DKSRLSAAAV DVQNTPQSTA VSLAQRTKAD GYGVFMTYNL PDGDVSPYVS
SMTKVLYGQA ATYH